These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3101349)

  • 1. Platelet survival in myelodysplastic syndromes.
    Efira A; Cauchie P; Rauis M; de Maertelaere E
    Acta Haematol; 1986; 76(2-3):124-6. PubMed ID: 3101349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood platelet function in chronic myeloid disorders. II. Myelodysplastic syndromes].
    Cieslar P; Matousová O
    Vnitr Lek; 1988 May; 34(5):441-8. PubMed ID: 3414027
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].
    Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.
    Heyns AD; Lötter MG; Pieters H; Pauw FH; Badenhorst PN; Wessels P; Minnaar PC
    Clin Nephrol; 1982 Oct; 18(4):174-82. PubMed ID: 6814802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet mass has prognostic value in patients with myelodysplastic syndromes.
    Bowles KM; Warner BA; Baglin TP
    Br J Haematol; 2006 Oct; 135(2):198-200. PubMed ID: 16939490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet function in the myelodysplastic syndromes.
    Rasi V; Lintula R
    Scand J Haematol Suppl; 1986; 45():71-3. PubMed ID: 3515523
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes.
    Germing U; Platzbecker U; Giagounidis A; Aul C
    Br J Haematol; 2007 Aug; 138(3):399-400. PubMed ID: 17555472
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
    Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet function and its clinical significance in the myelodysplastic syndromes.
    Zeidman A; Sokolover N; Fradin Z; Cohen A; Redlich O; Mittelman M
    Hematol J; 2004; 5(3):234-8. PubMed ID: 15167910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
    Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet destruction in autoimmune thrombocytopenic purpura: kinetics and clearance of indium-111-labeled autologous platelets.
    Stratton JR; Ballem PJ; Gernsheimer T; Cerqueira M; Slichter SJ
    J Nucl Med; 1989 May; 30(5):629-37. PubMed ID: 2497234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods.
    Vallabhajosula S; Machac J; Goldsmith SJ; Lipszyc H; Badimon L; Rand J; Fuster V
    J Nucl Med; 1986 Nov; 27(11):1669-74. PubMed ID: 3095509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet kinetic study in patients with idiopathic thrombocytopenic purpura (ITP) refractory or relapsing after corticosteroid treatment.
    Rossi G; Cattaneo C; Motta M; Pizzocaro C; Lanzi S; Pouchè A
    Hematol J; 2002; 3(3):148-52. PubMed ID: 12111651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of recombinant alpha 2 interferon in the myelodysplastic syndrome: II. Characterization and response of granulocyte and platelet dysfunction.
    Elias L; Van Epps DE; Smith KJ; Savage B
    Leukemia; 1987 Feb; 1(2):111-5. PubMed ID: 2823014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide subproteome alterations in the platelets of patients with myelodysplastic syndrome.
    Pecankova K; Majek P; Cermak J; Dyr JE
    J BUON; 2015; 20(6):1643-4. PubMed ID: 26854469
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet dysfunction in acute leukemias and myelodysplastic syndromes.
    Vlădăreanu AM; Vasilache V; Bumbea H; Onisâi M
    Rom J Intern Med; 2011; 49(1):93-6. PubMed ID: 22026258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic pure thrombocytopenia in elderly patients. An aspect of the myelodysplastic syndrome.
    Najean Y; Lecompte T
    Cancer; 1989 Dec; 64(12):2506-10. PubMed ID: 2819658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological analysis of the megakaryocytes in myelodysplastic syndrome].
    Mori H; Niikura H; Terada H; Fujita K
    Rinsho Byori; 1990 Dec; 38(12):1347-52. PubMed ID: 2082033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet kinetics with indium-111 platelets: comparison with chromium-51 platelets.
    Peters AM; Lavender JP
    Semin Thromb Hemost; 1983 Apr; 9(2):100-14. PubMed ID: 6346489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.
    Saigo K; Takenokuchi M; Imai J; Numata K; Isono S; Zenibayashi M; Tanioka H; Yoshioka T; Nishizawa A; Takada M; Nomura T; Kubota Y
    Lab Hematol; 2009; 15(2):13-6. PubMed ID: 19561008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.